INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENTIntellectual Property Assignment Agreement • January 19th, 2018 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 19th, 2018 Company Industry JurisdictionThis agreement (“Agreement”) is entered into as of January 16, 2018 (the “Effective Date”), by and between Dr. Charles E. Inturrisi, an individual, and Dr. Paolo Manfredi, an individual, jointly and severally (collectively, “Assignee”) and Relmada Therapeutics, Inc., a Nevada corporation (“Assignor”).
LICENSE AGREEMENT BETWEEN RELMADA THERAPEUTICS, INC. AND DR. PAOLO MANFREDI AND DR. CHARLES E. INTURRISI LICENSE AGREEMENTLicense Agreement • January 19th, 2018 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 19th, 2018 Company Industry JurisdictionThis agreement (“Agreement”) is entered into as of January 16, 2018 (the “Effective Date”), by and between Dr. Charles E. Inturrisi, an individual, and Dr. Paolo Manfredi, an individual, jointly and severally (collectively, “Licensor”) and Relmada Therapeutics, Inc., a Nevada corporation (“Licensee”).